Moreover, TUS was proven to regulate cancer cell proliferation, angiogenesis, and inflammation via Wnt, VEGFR2, and Irf and heme oxygenase-1 (HO-1) pathways, respectively (Li et al., 2014; Park et al., 2014; Li et al., 2019). The gene discussed is KDR; the disease is cancer.